Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar V Lerma

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
American Journal of Nephrology|January 22, 2024
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2Steven Fishbane, Deborah J Clegg, Edgar V Lerma, et al.
The Journal of Vascular Access|June 24, 2021
Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United StatesAnil K Agarwal, Adrian Sequeira, Bharvi P Oza-Gajera, et al.
The Journal of Vascular Access|July 5, 2021
PICC line management among patients with chronic kidney diseaseBharvi P Oza-Gajera, James A Davis, Crystal Farrington, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 27, 2020
Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trialsSimon D Roger, Bruce S Spinowitz, Edgar V Lerma, et al.
Kidney360|July 8, 2024
Mental Health and Autosomal Dominant Polycystic Kidney Disease: A Narrative ReviewNiloufar Ebrahimi, Pranav S Garimella, Fouad T Chebib, et al.
Cardiovascular Diabetology|August 7, 2019
Class effects of SGLT2 inhibitors on cardiorenal outcomesAaron Y Kluger, Kristen M Tecson, Andy Y Lee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 2, 2020
Erratum to: Sodium Zirconium Cyclosilicate Increases Serum Bicarbonate Concentrations Among Patients with Hyperkalaemia: Exploratory Analyses from Three Randomized, Multi-Dose, Placebo-Controlled TrialsSimon D Roger, Bruce S Spinowitz, Edgar V Lerma, et al.
American Heart Journal Plus : Cardiology Research and Practice|June 12, 2023
Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: A systematic review and meta-analysisFrederick Berro Rivera, Vincent Anthony S Tang, Deogracias Villa De Luna, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 14, 2017
Effects of staged versus ad hoc percutaneous coronary interventions on renal function-Is there a benefit to staging?Mahek Shah, Deepakraj Gajanana, David S Wheeler, et al.
Reviews in Cardiovascular Medicine|April 30, 2019
Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2Peter A McCullough, Aaron Y Kluger, Kristen M Tecson, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
American Journal of Nephrology|January 22, 2024
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2Steven Fishbane, Deborah J Clegg, Edgar V Lerma, et al.
The Journal of Vascular Access|June 24, 2021
Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United StatesAnil K Agarwal, Adrian Sequeira, Bharvi P Oza-Gajera, et al.
The Journal of Vascular Access|July 5, 2021
PICC line management among patients with chronic kidney diseaseBharvi P Oza-Gajera, James A Davis, Crystal Farrington, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 27, 2020
Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trialsSimon D Roger, Bruce S Spinowitz, Edgar V Lerma, et al.
Kidney360|July 8, 2024
Mental Health and Autosomal Dominant Polycystic Kidney Disease: A Narrative ReviewNiloufar Ebrahimi, Pranav S Garimella, Fouad T Chebib, et al.
Cardiovascular Diabetology|August 7, 2019
Class effects of SGLT2 inhibitors on cardiorenal outcomesAaron Y Kluger, Kristen M Tecson, Andy Y Lee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 2, 2020
Erratum to: Sodium Zirconium Cyclosilicate Increases Serum Bicarbonate Concentrations Among Patients with Hyperkalaemia: Exploratory Analyses from Three Randomized, Multi-Dose, Placebo-Controlled TrialsSimon D Roger, Bruce S Spinowitz, Edgar V Lerma, et al.
American Heart Journal Plus : Cardiology Research and Practice|June 12, 2023
Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: A systematic review and meta-analysisFrederick Berro Rivera, Vincent Anthony S Tang, Deogracias Villa De Luna, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 14, 2017
Effects of staged versus ad hoc percutaneous coronary interventions on renal function-Is there a benefit to staging?Mahek Shah, Deepakraj Gajanana, David S Wheeler, et al.
Reviews in Cardiovascular Medicine|April 30, 2019
Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2Peter A McCullough, Aaron Y Kluger, Kristen M Tecson, et al.
Pageof 11